Seattle, WA — Wednesday October 1, 2026 - Blink Anesthesia adds Lindsay Boyle, Ed.D, MBA to leadership team as VP of Commercial Operations
Blink Anesthesia announced today that Linsday Boyle, Ed.D, MBA joins the leadership team as Vice President of Commercial Operations.
Lindsay brings 20 years of experience at Medtronic, where she held leadership roles spanning sales, marketing, strategy, organizational transformation, and digital health. Most recently, she served as U.S. Business Leader for Digital Technologies within Medtronic’s Surgical business, leading the commercialization and adoption of innovative digital surgery solutions. Throughout her career, she has built and led teams, driven commercial growth, and partnered with healthcare executives to advance technologies that improve surgical care and patient outcomes.
She holds a Doctor of Education in Organizational Change and Leadership from the University of Southern California, an MBA in Strategic Leadership from Metropolitan State University of Denver, and a Bachelor of Arts in Religious Studies from the University of Colorado Boulder.
“Welcoming Lindsay to the leadership team marks another important step in our next chapter of growth to expand access to innovative neuromuscular monitoring technology and strengthen relationships with clinicians and healthcare systems. Her leadership will play a key role as we continue to scale our business and lead the shift toward safer anesthesia care,” said Justin Hulvershorn, MD, PhD, CEO of Blink Anesthesia.
About Blink Anesthesia:
Blink Device Company, LLC (dba Blink Anesthesia) is a Seattle-based medical device company dedicated to improving patient safety in anesthesia practice. Blink Anesthesia develops breakthrough anesthesia technology designed to improve patient safety. Its flagship product, the TwitchView® Train of Four Monitor, is a quantitative neuromuscular monitor that helps anesthetists eliminate residual paralysis and allows hospitals to align with the 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade.
Media Contact:
Leslie Aberman
Strategic Counsel and Business Affairs
leslie.aberman@blinkdc.com
Blink Device Company, LLC
